LABCORP HOLDINGS INC. 4

Labcorp CEO Adam H. Schechter sold 4,669 shares of Labcorp common stock for about $1.5 million under a Rule 10b5-1 trading plan.

On August 11, 2026, Labcorp Holdings Inc. President & CEO Adam H. Schechter sold 4,669 shares of Labcorp common stock at an average price of $320.37 per share, for total proceeds of approximately $1.50 million, in a transaction executed under a pre-arranged Rule 10b5-1 trading plan. Following this sale, Schechter beneficially owns 102,565 shares of Labcorp common stock, representing an estimated holding value of about $33.0 million based on the transaction price (or roughly $33.0 million using the current market price of $322.13), indicating that he continues to maintain a substantial equity stake in the company despite the sizable disposition.

Filing Facts

CIK

920148

Ticker

LH

Form

4

Source Type

fda

Accession

0000920148-26-000177

Alert Tier

7